1
|
Baldwin HE, Green LJ, Kircik L, Guenin EP, Forest AL, Pillai R. Tazarotene 0.045% Lotion for Moderate-to-Severe Acne in Male and Female Participants: A Phase II Post-hoc Analysis. J Clin Aesthet Dermatol 2021; 14:E53-E60. [PMID: 34055190 PMCID: PMC8142831] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
CLINICAL TRIALS ID: NCT02938494 BACKGROUND: In a Phase II study, tazarotene 0.045% lotion was statistically superior to vehicle and comparable to tazarotene 0.1% cream in reducing acne lesions, with fewer treatment-related adverse events (TEAEs) than the cream. OBJECTIVE: We analyzed data from the aforementioned study post-hoc to evaluate the effects of sex on treatment outcomes. METHODS: Participants aged 12 years or older with moderate-to-severe acne were randomized to tazarotene (0.045% lotion or 0.1% cream) or vehicle (lotion or cream) for 12 weeks of double-blind treatment. Outcomes analyzed in male and female subgroups included changes from baseline in inflammatory/noninflammatory lesions and TEAEs. RESULTS: In the intent-to-treat population (94 males and 116 females), reductions in lesion count were greater with tazarotene (lotion or cream) than with vehicle. In participants receiving tazarotene 0.045% lotion, the least-squares mean percent changes from baseline to Week 12 were greater in females than males, but the differences were not statistically significant (inflammatory [-70.3% vs. -56.2%]; noninflammatory [-60.0% vs. -53.2%]). In both females and males, the TEAE incidence was lower with tazarotene 0.045% lotion than 0.1% cream. CONCLUSION: Tazarotene 0.045% lotion substantially reduced acne lesions in both female and male participants. This newest tazarotene formulation might benefit patients who cannot tolerate older formulations or other topical retinoids. Given the relatively small size of this study, however, the results of this post-hoc analysis are intended to be exploratory in nature.
Collapse
Affiliation(s)
- Hilary E Baldwin
- Dr. Baldwin is with the Acne Treatment and Research Center in Brooklyn, New York, and Rutgers Robert Wood Johnson Medical Center in New Brunswick, New Jersey
- Dr. Green is with the Department of Dermatology at George Washington University School of Medicine in Washington, DC
- Dr. Kircik is with the Indiana University School of Medicine in Indianapolis, Indiana; Physicians Skin Care, PLLC, in Louisville, Kentucky; and the Icahn School of Medicine at Mount Sinai in New York, New York
- Dr. Guenin is with Ortho Dermatologics in Bridgewater, New Jersey. Ms. Forest and Dr. Pillai are with Bausch Health US, LLC in Petaluma, California
| | - Lawrence J Green
- Dr. Baldwin is with the Acne Treatment and Research Center in Brooklyn, New York, and Rutgers Robert Wood Johnson Medical Center in New Brunswick, New Jersey
- Dr. Green is with the Department of Dermatology at George Washington University School of Medicine in Washington, DC
- Dr. Kircik is with the Indiana University School of Medicine in Indianapolis, Indiana; Physicians Skin Care, PLLC, in Louisville, Kentucky; and the Icahn School of Medicine at Mount Sinai in New York, New York
- Dr. Guenin is with Ortho Dermatologics in Bridgewater, New Jersey. Ms. Forest and Dr. Pillai are with Bausch Health US, LLC in Petaluma, California
| | - Leon Kircik
- Dr. Baldwin is with the Acne Treatment and Research Center in Brooklyn, New York, and Rutgers Robert Wood Johnson Medical Center in New Brunswick, New Jersey
- Dr. Green is with the Department of Dermatology at George Washington University School of Medicine in Washington, DC
- Dr. Kircik is with the Indiana University School of Medicine in Indianapolis, Indiana; Physicians Skin Care, PLLC, in Louisville, Kentucky; and the Icahn School of Medicine at Mount Sinai in New York, New York
- Dr. Guenin is with Ortho Dermatologics in Bridgewater, New Jersey. Ms. Forest and Dr. Pillai are with Bausch Health US, LLC in Petaluma, California
| | - Eric Pierre Guenin
- Dr. Baldwin is with the Acne Treatment and Research Center in Brooklyn, New York, and Rutgers Robert Wood Johnson Medical Center in New Brunswick, New Jersey
- Dr. Green is with the Department of Dermatology at George Washington University School of Medicine in Washington, DC
- Dr. Kircik is with the Indiana University School of Medicine in Indianapolis, Indiana; Physicians Skin Care, PLLC, in Louisville, Kentucky; and the Icahn School of Medicine at Mount Sinai in New York, New York
- Dr. Guenin is with Ortho Dermatologics in Bridgewater, New Jersey. Ms. Forest and Dr. Pillai are with Bausch Health US, LLC in Petaluma, California
| | - Anya Loncaric Forest
- Dr. Baldwin is with the Acne Treatment and Research Center in Brooklyn, New York, and Rutgers Robert Wood Johnson Medical Center in New Brunswick, New Jersey
- Dr. Green is with the Department of Dermatology at George Washington University School of Medicine in Washington, DC
- Dr. Kircik is with the Indiana University School of Medicine in Indianapolis, Indiana; Physicians Skin Care, PLLC, in Louisville, Kentucky; and the Icahn School of Medicine at Mount Sinai in New York, New York
- Dr. Guenin is with Ortho Dermatologics in Bridgewater, New Jersey. Ms. Forest and Dr. Pillai are with Bausch Health US, LLC in Petaluma, California
| | - Radhakrishnan Pillai
- Dr. Baldwin is with the Acne Treatment and Research Center in Brooklyn, New York, and Rutgers Robert Wood Johnson Medical Center in New Brunswick, New Jersey
- Dr. Green is with the Department of Dermatology at George Washington University School of Medicine in Washington, DC
- Dr. Kircik is with the Indiana University School of Medicine in Indianapolis, Indiana; Physicians Skin Care, PLLC, in Louisville, Kentucky; and the Icahn School of Medicine at Mount Sinai in New York, New York
- Dr. Guenin is with Ortho Dermatologics in Bridgewater, New Jersey. Ms. Forest and Dr. Pillai are with Bausch Health US, LLC in Petaluma, California
| |
Collapse
|